FOCALIN

This brand name is authorized in United States. It is also authorized in Estonia.

Active ingredients

The drug FOCALIN contains one active pharmaceutical ingredient (API):

1	Dexmethylphenidate UNII 1678OK0E08 - DEXMETHYLPHENIDATE HYDROCHLORIDE
	Dexmethylphenidate is a CNS stimulant. It is the more pharmacologically active d-enantiomer of racemic methylphenidate. Methylphenidate blocks the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extraneuronal space. The mode of therapeutic action in Attention Deficit Hyperactivity Disorder (ADHD) is not known.
	Read more about Dexmethylphenidate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FOCALIN Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06BA11		N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BA Centrally acting sympathomimetics
Discover more medicines within N06BA11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1748987
US	FDA, National Drug Code	0078-0380, 0078-0381, 0078-0382, 0078-0430, 0078-0431, 0078-0432, 0078-0433, 0078-0434, 0078-0493, 0078-0608, 0078-0609